2772-9478

iLiver

Elsevier

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 181 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact181 DOIs
2

Attach ORCID iDs across 49 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Medium impact49 DOIs
3

Deposit reference lists for 5 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact5 DOIs

DOIs for this ISSN

Showing the top 5 of 181 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Perihilar cholangiocarcinoma: a surgeon's perspective (10.1016/j.iliver.2022.03.004)
Abstract ORCID
58.80 14
2 Traditional Chinese medicine diagnosis and treatment based o… (10.1016/j.iliver.2023.08.004)
Abstract ORCID
57.31 13
3 Integrating mixed reality, augmented reality, and artificial… (10.1016/j.iliver.2025.100167)
Abstract ORCID
55.70 12
4 Myeloid-derived suppressor cells in cancer (10.1016/j.iliver.2022.06.002)
Abstract ORCID
52.07 10
5 Radiomics/Radiogenomics in hepatocellular carcinoma: Applica… (10.1016/j.iliver.2022.07.001)
Abstract ORCID
52.07 10
6 WGCNA combined with machine learning to explore potential bi… (10.1016/j.iliver.2024.100133)
Abstract ORCID
52.07 10
7 Ascorbic acid ameliorates isoniazid-rifampicin-induced hepat… (10.1016/j.iliver.2022.03.001)
Abstract ORCID
50.00 9
8 Exploratory study of microparticle transcatheter arterial ch… (10.1016/j.iliver.2022.01.001)
Abstract ORCID
45.15 7
9 Glycemic control predicts the risk of hepatic fibrosis in bi… (10.1016/j.iliver.2022.02.001)
Abstract ORCID
42.25 6
10 Application of biological big data and radiomics in hepatoce… (10.1016/j.iliver.2023.01.003)
Abstract ORCID
42.25 6
11 Artificial intelligence-based pathological analysis of liver… (10.1016/j.iliver.2024.100082)
Abstract ORCID
42.25 6
12 Emerging role of molecular diagnosis and personalized therap… (10.1016/j.iliver.2024.100083)
Abstract
40.05 39
13 Anatomical hepatectomy for achieving textbook outcome for pe… (10.1016/j.iliver.2022.10.004)
Abstract ORCID
38.91 5
14 Clinical analysis of the characteristics of patients diagnos… (10.1016/j.iliver.2022.05.001)
Abstract ORCID
34.95 4
15 Applications of neural networks in liver transplantation (10.1016/j.iliver.2022.07.002)
Abstract ORCID
34.95 4
16 Analysis of efficacy and safety for the combination of regor… (10.1016/j.iliver.2024.100092)
Abstract ORCID
34.95 4
17 Network pharmacology and single-cell transcriptomic analysis… (10.1016/j.iliver.2024.100115)
Abstract ORCID
34.95 4
18 Innovations in 3D bioprinting and biomaterials for liver tis… (10.1016/j.iliver.2024.100080)
Abstract
31.38 17
19 New approaches to the treatment of metabolic dysfunction-ass… (10.1016/j.iliver.2024.100131)
Abstract
30.76 16
20 The pathophysiological mechanism between hypopituitarism and… (10.1016/j.iliver.2022.02.004)
Abstract ORCID
30.10 3
21 A HRG novel mutation associated with idiopathic portal hyper… (10.1016/j.iliver.2022.06.001)
Abstract ORCID
30.10 3
22 Feasibility of surgical application of the ligamentum teres… (10.1016/j.iliver.2023.01.005)
Abstract ORCID
30.10 3
23 Serum IP-10 increase correlated with PEG-IFNα response in nu… (10.1016/j.iliver.2024.100107)
Abstract ORCID
30.10 3
24 Research advances in treatment strategies for breast cancer… (10.1016/j.iliver.2025.100186)
Abstract ORCID
30.10 3
25 Pathogenesis of metabolic dysfunction-associated steatotic l… (10.1016/j.iliver.2025.100195)
Abstract
29.40 14
26 Advances in magnetic particle imaging and perspectives on li… (10.1016/j.iliver.2022.10.003)
Abstract
28.65 13
27 When liver disease diagnosis encounters deep learning: Analy… (10.1016/j.iliver.2023.02.002)
Abstract
28.65 13
28 Transarterial chemoembolization in combination with programm… (10.1016/j.iliver.2022.10.001)
Abstract
26.98 11
29 Diagnostic performance comparisons of two commonly used mult… (10.1016/j.iliver.2024.100098)
Abstract
26.98 11
30 Liver transplantation for malignant liver tumors (10.1016/j.iliver.2022.04.002)
Abstract
26.03 10
31 Artificial intelligence-based ultrasound imaging technologie… (10.1016/j.iliver.2022.11.001)
Abstract
26.03 10
32 The transjugular intrahepatic portosystemic shunt: Smaller s… (10.1016/j.iliver.2023.05.004)
Abstract
26.03 10
33 Advances in diagnostic ultrasound techniques for assessing l… (10.1016/j.iliver.2023.10.002)
Abstract
26.03 10
34 Systematic review and meta-analysis: Comparing hepatocellula… (10.1016/j.iliver.2023.05.002)
Abstract
25.00 9
35 Systematic treatment in unresectable hepatocellular carcinom… (10.1016/j.iliver.2024.100112)
Abstract
25.00 9
36 Associating liver partition and portal vein ligation for sta… (10.1016/j.iliver.2022.02.002)
Abstract ORCID
23.86 2
37 Anxiety and depression in older adult patients undergoing el… (10.1016/j.iliver.2022.05.002)
Abstract ORCID
23.86 2
38 Effects of Raf kinase inhibitor protein on biological charac… (10.1016/j.iliver.2022.11.005)
Abstract ORCID
23.86 2
39 Hepatocellular Carcinoma Gene Expression: The New Era, Where… (10.1016/j.iliver.2022.12.001)
Abstract
23.86 8
40 Free fatty acid-induced miR-22 inhibits gluconeogenesis via… (10.1016/j.iliver.2023.01.002)
Abstract
23.86 8
41 Altered expression in liver cancer with various hepatic bloo… (10.1016/j.iliver.2023.04.001)
Abstract ORCID
23.86 2
42 Increased attention to women with drug-induced liver injury:… (10.1016/j.iliver.2024.100125)
Abstract ORCID
23.86 2
43 Contrast-enhanced US and contrast-enhanced CT for diagnosis… (10.1016/j.iliver.2025.100147)
Abstract ORCID
23.86 2
44 Latest innovations in the treatment of Wilson's disease (10.1016/j.iliver.2022.09.002)
Abstract
22.58 7
45 Prednisolone therapy accelerates recovery of severe drug-ind… (10.1016/j.iliver.2023.06.001)
Abstract
22.58 7
46 AI-driven multimodal fusion of tongue images and clinical in… (10.1016/j.iliver.2025.100181)
Abstract
22.58 7
47 Optimising postoperative surveillance for hepatocellular car… (10.1016/j.iliver.2024.100110)
Abstract
21.13 6
48 Emerging role of natural bioactive compounds in navigating t… (10.1016/j.iliver.2024.100140)
Abstract
21.13 6
49 Artificial intelligence in hepatology: A comprehensive scopi… (10.1016/j.iliver.2025.100205)
Abstract
21.13 6
50 A high level of secreted phosphoprotein 1 is associated with… (10.1016/j.iliver.2023.01.004)
Abstract
19.45 5